Plasma-derived human factor X concentrate for on-demand and perioperative treatment in factor X-deficient patients: pharmacology, pharmacokinetics, efficacy, and safety-Reference-Cited by-同舟云学术

Plasma-derived human factor X concentrate for on-demand and perioperative treatment in factor X-deficient patients: pharmacology, pharmacokinetics, efficacy, and safety

Published:2016-11-02 Issue:1 Volume:13 Page:97-104
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Shapiro Amy

Funder

Bio Products Laboratory Ltd

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/17425255.2016.1237504

Reference32 articles.

1. Guideline for the diagnosis and management of the rare coagulation disorders

2. The rare coagulation disorders - review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation

3. Factor X deficiency

4. Rare bleeding disorders: diagnosis and treatment

5. Diagnosis and treatment of inherited factor X deficiency

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical, Laboratory Aspects and Management of Factor X Deficiency;Seminars in Thrombosis and Hemostasis;2024-08-29

2. Plasma‐derived human factor X concentrate for the treatment of patients with hereditary factor X deficiency;Haemophilia;2023-10-30

3. Umbilical Cord Bleeding in a Neonate;NeoReviews;2023-03-01

4. Management of rare inherited bleeding disorders: Proposals of the French Reference Centre on Haemophilia and Rare Coagulation Disorders;European Journal of Haematology;2023-02-20

5. Congenital Factor X Deficiency, Diagnosis, and Management;Congenital Bleeding Disorders;2023